Clear ×
Emergent BioSolutions Inc. EBS

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 16, 2026 8-K 3 signals fired
Other
Executive Educational Background Disclosure Executive Transition Gratitude Statement
Core
Management Exodus
Sep 14, 2026 8-K 4 signals fired
Other
Gross Margin Comparison Disclosed Restructuring Initiated Adjusted Ebitda Period Comparison Restructuring Charge Disclosed
Sep 1, 2026 8-K 1 signal fired
Core
Clinical Trial Result
Aug 5, 2026 10-Q 39 signals fired · top 15
Other
Quarterly Tax Provision Benefit Disclosure Restructuring Charge Disclosed Effective Tax Rate Reconciliation Share Repurchase Activity Disclosed Sga Expense Comparison Disclosed Cash Flow Statement Investing Activities Goodwill Impairment Financing Activities Cash Flow Disclosure Segment Aggregation Disclosure Gross Margin Comparison Disclosed Impairment Charge Breakdown Revenue Increase Attribution Disclosure Fifo Inventory Valuation Disclosed
Healthcare
Pricing Power Services
Business Services
Demand Softening
Aug 5, 2026 8-K 27 signals fired · top 15
Other
Adjusted Ebitda Period Comparison Restructuring Charge Disclosed Workforce Reduction Restructuring Plan Sga Expense Comparison Disclosed Gross Margin Comparison Disclosed Goodwill Impairment Pricing Power Expanding Board Committee Member Listing Net Loss Reported
Healthcare
Pricing Power Services Utilization Improving Reimbursement Improving
SaaS
Recurring Revenue Growing
Business Services
Demand Softening
Core
Management Exodus
Apr 30, 2026 10-Q 32 signals fired · top 15
Other
Share Repurchase Activity Disclosed Effective Tax Rate Reconciliation Administrative Efficiency Ltip Plan Title Citation Sga Expense Comparison Disclosed Quarterly Tax Provision Benefit Disclosure Libor Based Term Loan Pricing Cash Flow Statement Investing Activities Allowance For Credit Losses Methodology Disclosed Goodwill Impairment Burn Rate Controlled Gross Margin Comparison Disclosed Financing Activities Cash Flow Disclosure Term Loan B Holding Disclosure
Business Services
Demand Softening
Apr 30, 2026 8-K 14 signals fired
Other
Share Repurchase Activity Disclosed Administrative Efficiency Revenue Decline Explanation Sga Expense Comparison Disclosed Operating Margin Declining Gross Margin Comparison Disclosed Pricing Pressure Debt Refinanced Favorably Burn Rate Controlled Earnings Call Replay Details Personnel Cost Decrease Disclosure
Business Services
Demand Softening
Healthcare
Utilization Declining Services Pricing Power Services